Catalyst Wire Dossier Catalyst Wire Dossier

SPN-810M

viloxazine · Supernus Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SPN-810M, covering 2016-05-13 to 2016-05-13. Get the full timeline:

Most recent: Clinical Trial Update: Phase I Study to Assess the Absorption, Metabolism, and Excretion of [14C] Labeled SPN-810M [Phase 1]

See pricing